1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Rhabdomyosarcoma, Abdominal: new trials by email Literature Review of Rhabdomyosarcoma, Abdominal trials Research Report on Rhabdomyosarcoma, Abdominal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children Abdominal Surgery, Doxorubicin, Intra-Operative Radiation - Malignant Neoplasms of Mesothelial and Soft Tissue, Rhabdomyosarcoma, Pelvic | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2018-08-01 | 2018-07-20 |
Abdominal Neoplasms (1) · Rhabdomyosarcoma (1)
Myosarcoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Muscle Tissue (1) · Sarcoma (1)
Doxorubicin (1)
M.D. Anderson Cancer Center (1)